DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR XARELTO
Clinical Trials for Xarelto
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00831714 | Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty | Completed | Bayer | N/A | 2009-02-01 | The main goal is to provide additional information to the risk-benefit assessment of the drug. |
| NCT01029743 | Xarelto Regulatory Post-Marketing Surveillance | Completed | Bayer | N/A | 2009-12-01 | This study is to identify the following problems and questions with respect to the safety and effectiveness of Xarelto in comparison with other pharmacologic agents in the prophylaxis of venous thromboembolism (VTE) in a large sample of patients who undergo elective total hip replacement (THR) or total knee replacement (TKR) in the real-life conditions in its registered indication(s) as required by Korean Food and Drug Administration (KFDA). 1. Known and unknown adverse reactions, especially serious adverse reactions 2. Incidence of adverse reactions under the routine drug use 3. Factors that may affect the safety of the drug 4. Factors that may affect the effectiveness of the drug 5. Other safety information related to overuse, drug interaction and laboratory abnormalities 6. Other adverse reactions |
| NCT01210755 | Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics | Completed | University Hospital, Grenoble | Phase 4 | 2010-11-01 | The purpose of this study is to evaluate whether the effect of the two new anticoagulants, Dabigatran and Rivaroxaban, can be reversed by non-specific and specific inhibitors. For Dabigatran the investigators will test the non-specific inhibitors: prothrombin complex concentrate (PCC), recombinant activated coagulation factor VII, and activated prothrombin-complex (FEIBA). For Rivaroxaban the investigators will test a specific Rivaroxaban decoy (FXa-GLAless). This will be done in a laboratory using blood plasma from healthy male volunteers. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Xarelto
Condition Name
Clinical Trial Locations for Xarelto
Trials by Country
Clinical Trial Progress for Xarelto
Clinical Trial Phase
Clinical Trial Sponsors for Xarelto
Sponsor Name
